August 28, 2025
Why MI Experts Can Reduce Operational Burden for Pharma Companies
Discover how partnering with MI experts at ProPharma can reduce operational burdens, enhance compliance, and improve efficiency for pharmaceutical companies.
ProPharma's contact center is trained on Adverse Event (AE) detection and intake since onboarding as part of Medical Information (MI) processing. We ensure that every AE is collected for patients' safety, customer journey, and compliance at every customer interaction. For a seamless experience, ProPharma offers comprehensive AE processing and reporting through our dedicated Pharmacovigilance (PV) team to supplement or fully outsource your existing PV function.
Identification and Accurate Reporting of Adverse Event
Identification and Accurate Reporting of Adverse Event
Central Point of Contact
As a trusted partner, ProPharma serves as an extension of your company, acting as a central hub for both your internal staff and external customers in the pre-marketing and post-marketing space. We speak the local language, and able to collect Adverse Events (AEs) and Special Safety Events (SSE) through various reporting channels, including traditional methods like phone and email, as well as newer platforms such as social media and live chat. The ProPharma Medical Information Contact Center (MICC) provides a centralized and streamlined AE reporting process, eliminating duplicate information from different programs and significantly reducing administrative complexity and time in AE processing.
Our global presence ensures easy approach to our contact center, even in crisis situations. Our scalable and adaptable strategies provide continuous business support during spikes in call volume, regulatory changes, or product market withdrawals, offering consistent medical information and safety assistance.
ProPharma’s Advanced Contact Center Technology in Pharmacovigilance
Efficient Triage with IVR and Call Redirection
Our Interactive Voice Response (IVR) system and call redirection capabilities significantly enhance our triage processes. By efficiently routing calls to the appropriate representatives, we ensure that inquiries related to Adverse Events (AEs) are addressed promptly and accurately. This technology minimizes wait times and improves the overall experience for both patients and healthcare providers.
Smart Report Generation
Our smart report generation tool automates the merging of content directly from the intake process, greatly reducing the potential for errors associated with manual reporting. This streamlined case processing workflow not only improves accuracy but also expedites the generation of essential reports. As a result, our teams can dedicate more time to critical safety assessments and less to administrative tasks.
Automated Follow-Up
Our follow-up automation system streamlines the process of sending forms and collecting additional information through written communication, significantly reducing administrative workloads. By automating these follow-up tasks, we ensure timely communication with stakeholders while freeing up valuable resources within your team. This efficiency enhances our ability to maintain thorough and accurate records of all interactions related to AEs.
Advanced Analytics for Duplicated Reports
With advanced analytical tools, we can effectively reconcile the duplicated reports and information. This capability helps identify discrepancies and confirms that all data is accurately reflected in the systems. We help enhancing the integrity of data, which is crucial for making informed safety decisions and maintaining compliance with regulatory standards.
Our Adverse Event Intake Experts
-
Dave Bezick
Senior Director, Medical Information
View Bio
-
Hannah Hunter
Senior Director, Medical Information
View Bio
-
Katie Tonge
Senior Director, Medical Information
View Bio
-
Leanne Shaw
Senior Director, Medical Information
View Bio
News & Insights
Thought Leadership Webinars Press Awards Resource Library
August 26, 2025
Maximizing Clinical Trial Success: Strategic Approaches for Adding EU Member Sta...
Successfully expand clinical trials to additional EU Member States under the CTR framework. Explore strategies for patient recruitment, regulatory compliance, and minimizing CTIS approval delays.
August 25, 2025
Selecting a PMPV Vendor, Part II: Building on a Strong Foundation
Discover the essentials of selecting the right pharmacovigilance vendor for post-marketing safety, ensuring compliance, flexibility, and effective signal detection.
.png?width=320&height=185&name=Global%20MLR%20Review%20(RS).png)
News & Insights
July 8, 2025
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...
ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...
January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 21, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer
ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.
